Shruti H Mehta
Overview
Explore the profile of Shruti H Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
339
Citations
6994
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Social support and HIV management among people who inject drugs: in-depth interviews in Delhi, India
Kaptchuk R, Kant A, Shekhawat S, Baishya J, Sinha A, Kedar A, et al.
Harm Reduct J
. 2025 Mar;
22(1):32.
PMID: 40087767
Background: People who inject drugs (PWID) experience a higher burden of HIV compared to general populations. Social support has been shown to improve disease management and combat stigma for PWID...
2.
Piggott D, Mehta S, Rubin L, Sun J, Leng S, Kirk G
AIDS
. 2025 Mar;
PMID: 40053483
Objective: Cognitive impairment and frailty are critical aging-related phenotypes prevalent among people living with HIV (PLWH). Yet, limited data exist isolating the determinants of cognitive function among persons with a...
3.
Patel E, Rudolph J, Feder K, Zhu X, Astemborski J, Lau B, et al.
Int J Drug Policy
. 2025 Mar;
138:104746.
PMID: 40037106
Background: The COVID-19 pandemic prompted many structural and social changes including adaptations to drug treatment policies and provision (e.g., take-home methadone flexibilities and telehealth services), but their collective impact on...
4.
Lopes S, Dotherow J, Pericot-Valverde I, Lum P, Taylor L, Mehta S, et al.
Drug Alcohol Depend
. 2025 Mar;
270:112617.
PMID: 40031361
Introduction: Integrating patient navigation (PN) interventions in hepatitis C virus (HCV) elimination efforts enhances HCV treatment cascade outcomes from screening to cure. Nonetheless, little is known about how the patient-navigator...
5.
Obeysekare J, Pericot-Valverde I, Lopes S, Groome M, Norton B, Tsui J, et al.
Drug Alcohol Depend
. 2025 Feb;
270:112592.
PMID: 39999625
Background: Anxiety disorders frequently occur in people who inject drugs (PWID). This study aimed to explore changes in anxiety among PWID during and after treatment of hepatitis C virus (HCV)...
6.
Wang J, Genberg B, Feder K, Feder K, Kirk G, Mehta S, et al.
J Infect Dis
. 2024 Dec;
PMID: 39657251
Background: The COVID-19 pandemic may have disproportionally impacted vulnerable groups such as people who inject drugs (PWID) through reduced healthcare services as well as social changes from pandemic mitigation measures....
7.
McFall A, Ganapathi L, Gunaratne M, Srikrishnan A, Vasudevan C, Anand S, et al.
Addiction
. 2024 Nov;
120(4):745-755.
PMID: 39604070
Aims: The aim of this study was to identify longitudinal trajectories of medication for opioid use disorder (MOUD) use throughout 1 year following MOUD initiation and to examine the association...
8.
Mehta S, Lau B, Ehrhardt S, McFall A, Gunaratne M, Baishya J, et al.
Am J Epidemiol
. 2024 Nov;
PMID: 39572371
Efforts to eliminate hepatitis C virus (HCV) as a public health problem must include people who inject drugs (PWID). We describe the design and baseline characteristics of the Supporting Treatment...
9.
Gunaratne M, Kedar A, McFall A, Srikrishnan A, Chingtham S, Amrose P, et al.
Int J Drug Policy
. 2024 Nov;
134:104635.
PMID: 39500224
Background: Reinfection with hepatitis C virus (HCV) following successful treatment with direct-acting antivirals (DAAs) is a threat to achieving the World Health Organization viral hepatitis elimination goals. Given the limited...
10.
Tsui J, Ludwig-Barron N, James J, Heo M, Sivaraj L, Arnsten J, et al.
J Addict Med
. 2024 Oct;
PMID: 39475112
Background: Questions remain on the relationship between pain and hepatitis C virus cure among persons who inject drugs (PWID). This study aimed to explore whether achieving hepatitis C virus cure...